Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-κB and MAPK pathways

References

• Väänänen HK, Zhao H. Osteoclast function: biology and mechanisms. In: Bilezikian JP, Raisz LG, Martin TJ, ed. Principles of bone biology. 3rd ed. San Diego: Academic Press; 2008:193–209
   Google Scholar
• Schinke T, Karsenty G. Transcriptional control of osteoblast differentiation and function. In: Bilezikian JP, Raisz LG, Martin TJ, ed. Principles of bone biology. 3rd ed. San Diego: Academic Press; 2008:109–19
   Google Scholar
• Leibbrandt A, Penninger J. RANK(L) as a key target for controlling bone loss. Adv Exp Med Biol 647:130–45
   Google Scholar
• Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 2007;9:S1
   PubMed Web of Science ®Google Scholar
• Galibert L, Tometsko ME, Anderson DM, Cosman D, Dougall WC. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem 1998;273:34120–7
   PubMed Web of Science ®Google Scholar
• Leibbrandt A, Penninger JM. RANK/RANKL: regulators of immune responses and bone physiology. Ann NY Acad Sci 2008;1143:123–50
   PubMed Web of Science ®Google Scholar
• Wisutsitthiwong C, Buranaruk C, Pudhom K, Palaga T. The plant limonoid 7-oxo-deacetoxygedunin inhibits RANKL-induced osteoclastogenesis by suppressing activation of the NF-kappaB and MAPK pathways. Biochem Biophys Res Commun 2011;415:361–6
   PubMed Web of Science ®Google Scholar
• Yoon WJ, Kim KN, Heo SJ, Han SC, Kim J, Ko YJ, Kang HK, Yoo ES. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-kappaB and MAPKs in RANKL-induced RAW 264.7 cells. Biochem Biophys Res Commun 2013;434:892–7
   PubMed Web of Science ®Google Scholar
• Ang ES, Yang X, Chen H, Liu Q, Zheng MH, Xu J. Naringin abrogates osteoclastogenesis and bone resorption via the inhibition of RANKL-induced NF-kappaB and ERK activation. FEBS Lett 2011;585:2755–62
   PubMed Web of Science ®Google Scholar
• Ha H, Shim KS, An H, Kim T, Ma JY. Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption. BMC Complement Altern Med 2013;13:112
   PubMed Web of Science ®Google Scholar
• Pramod K, Ansari SH, Ali J. Eugenol: a natural compound with versatile pharmacological actions. Nat Prod Commun 2010;5:1999–2006
   PubMed Web of Science ®Google Scholar
• Jaganathan SK, Supriyanto E. Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells. Molecules 2012;17:6290–304
   PubMed Web of Science ®Google Scholar
• Boeyens JC, Deepak V, Chua WH, Kruger MC, Joubert AM, Coetzee M. Effects of omega3- and omega6-polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study. Nutrients 2014;6:2584–601
   Google Scholar
• Janckila AJ, Takahashi K, Sun SZ, Yam LT. Naphthol-ASBI phosphate as a preferred substrate for tartrate-resistant acid phosphatase isoform 5b. J Bone Miner Res 2001;16:788–93
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) Method. Methods 2001;25:402–8
   PubMed Web of Science ®Google Scholar
• Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Meth 2012;9:671–5
   PubMed Web of Science ®Google Scholar
• Helfrich MH. Osteoclast diseases. Microsc Res Tech 2003;61:514–32
   PubMed Web of Science ®Google Scholar
• Roux S, Orcel P. Bone loss. Factors that regulate osteoclast differentiation: an update. Arthritis Res 2000;2:451–6
   PubMedGoogle Scholar
• Pettit AR, Ji H, von Stechow D, Muller R, Goldring SR, Choi Y, Benoist C, Gravallese EM. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001;159:1689–99
   PubMed Web of Science ®Google Scholar
• Kim SS, Oh OJ, Min HY, Park EJ, Kim Y, Park HJ, Nam Han Y, Lee SK. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sci 2003;73:337–48
   PubMed Web of Science ®Google Scholar
• Manikandan P, Vinothini G, Vidya Priyadarsini R, Prathiba D, Nagini S. Eugenol inhibits cell proliferation via NF-kappaB suppression in a rat model of gastric carcinogenesis induced by MNNG. Invest New Drugs 2011;29:110–17
   PubMed Web of Science ®Google Scholar
• Nam H, Kim MM. Eugenol with antioxidant activity inhibits MMP-9 related to metastasis in human fibrosarcoma cells. Food Chem Toxicol 2013;55:106–12
   PubMed Web of Science ®Google Scholar
• Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem 2005;280:5812–19
   PubMed Web of Science ®Google Scholar
• Collin-Osdoby P, Osdoby P. RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods Mol Biol 2012;816:187–202
   PubMedGoogle Scholar
• Choi CY, Park KR, Lee JH, Jeon YJ, Liu KH, Oh S, Kim DE, Yea SS. Isoeugenol suppression of inducible nitric oxide synthase expression is mediated by down-regulation of NF-kappaB, ERK1/2, and p38 kinase. Eur J Pharmacol 2007;576:151–9
   PubMed Web of Science ®Google Scholar
• Nagababu E, Rifkind JM, Boindala S, Nakka L. Assessment of antioxidant activity of eugenol in vitro and in vivo. Methods Mol Biol 2010;610:165–80
   PubMedGoogle Scholar
• Fujisawa S, Atsumi T, Kadoma Y, Sakagami H. Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology 2002;177:39–54
   PubMed Web of Science ®Google Scholar
• Gulcin I. Antioxidant activity of eugenol: a structure-activity relationship study. J Med Food 2011;14:975–85
   PubMed Web of Science ®Google Scholar
• Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N, Lee SY. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005;106:852–9
   PubMed Web of Science ®Google Scholar
• Väänänen K, Zhao H. Osteoclast function: biology and mechanisms. In: Bilezikian JP, Raisz LG, Rodan GA, ed. Principles of bone biology, 2nd ed. San Diego: Academic Press; 2002:127–40
   Google Scholar
• Saftig P, Hunziker E, Everts V, Jones S, Boyde A, Wehmeyer O, Suter A, von Figura K. Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv Exp Med Biol 2000;477:293–303
   PubMed Web of Science ®Google Scholar
• Hollberg K, Hultenby K, Hayman A, Cox T, Andersson G. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. Exp Cell Res 2002;279:227–38
   PubMed Web of Science ®Google Scholar
• Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Luth A, Koskivirta I, Kleuser B, Vacher J, Vuorio E, Horne WC, Baron R. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest 2013;123:666–81
   PubMed Web of Science ®Google Scholar
• Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996;273:1236–8
   PubMed Web of Science ®Google Scholar
• Rodrigues C, Costa-Rodrigues J, Capelas JA, Fernandes MH. Behaviour of co-cultured human osteoclastic and osteoblastic cells exposed to endodontic sealers’ extracts. Clin Oral Investig 2014;18:479–88
   PubMed Web of Science ®Google Scholar
• Rodrigues C, Costa-Rodrigues J, Capelas JA, Fernandes MH. Long-term dose- and time-dependent effects of endodontic sealers in human in vitro osteoclastogenesis. J Endod 2013;39:833–8
   PubMed Web of Science ®Google Scholar
• Boyce BF, Zuscik MJ, Xing L. Biology of bone and cartilage. In: Thakker RV, Whyte MP, Eisman JA, Igarashi T, ed. Genetics of bone biology and skeletal disease. San Diego: Academic Press; 2013:3–24
   Google Scholar
• Yeh JL, Hsu JH, Hong YS, Wu JR, Liang JC, Wu BN, Chen IJ, Liou SF. Eugenolol and glyceryl-isoeugenol suppress LPS-induced iNOS expression by down-regulating NF-kappaB AND AP-1 through inhibition of MAPKS and AKT/IkappaBalpha signaling pathways in macrophages. Int J Immunopathol Pharmacol 2011;24:345–56
   PubMed Web of Science ®Google Scholar
• Magalhaes CB, Riva DR, DePaula LJ, Brando-Lima A, Koatz VL, Leal-Cardoso JH, Zin WA, Faffe DS. In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury. J Appl Physiol 2010;108:845–51
   PubMed Web of Science ®Google Scholar
• Kaur G, Athar M, Alam MS. Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis. Mol Carcinog 2010;49:290–301
   PubMed Web of Science ®Google Scholar
• Boyce BF. Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts. J Bone Miner Res 2013;28:711–22
   PubMed Web of Science ®Google Scholar
• Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 2004;114:475–84
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem 2000;275:31155–61
   PubMed Web of Science ®Google Scholar
• Matsushita T, Chan YY, Kawanami A, Balmes G, Landreth GE, Murakami S. Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol 2009;29:5843–57
   PubMed Web of Science ®Google Scholar
• He Y, Staser K, Rhodes SD, Liu Y, Wu X, Park SJ, Yuan J, Yang X, Li X, Jiang L, Chen S, Yang FC. Erk1 positively regulates osteoclast differentiation and bone resorptive activity. PLoS One 2011;6:e24780
   PubMed Web of Science ®Google Scholar
• David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci 2002;115:4317–25
   PubMed Web of Science ®Google Scholar